Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide receptor subtypes in mouse calvarial osteoblasts: presence of VIP-2 receptors and differentiation-induced expression of VIP-1 receptors.
about
Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis.Effects of neuropeptides and mechanical loading on bone cell resorption in vitro.Substance P activates the Wnt signal transduction pathway and enhances the differentiation of mouse preosteoblastic MC3T3-E1 cells.The serotonin 5-HT2B receptor controls bone mass via osteoblast recruitment and proliferation.Differential regulatory role of pituitary adenylate cyclase-activating polypeptide in the serum-transfer arthritis model.Bone and brain: a review of neural, hormonal, and musculoskeletal connections.Aging and bone loss: new insights for the clinician.Crosstalk between the brain and bone.The neuropeptide VIP regulates the expression of osteoclastogenic factors in osteoblasts.AGS3 and signal integration by Galpha(s)- and Galpha(i)-coupled receptors: AGS3 blocks the sensitization of adenylyl cyclase following prolonged stimulation of a Galpha(i)-coupled receptor by influencing processing of Galpha(i).Expression of pituitary adenylate cyclase-activating peptide (PACAP) and PAC1 in the periodontal ligament after tooth luxation.Greater bone formation of Y2 knockout mice is associated with increased osteoprogenitor numbers and altered Y1 receptor expression.Exercise and bone health across the lifespan.Signalling Alterations in Bones of Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) Gene Deficient Mice
P2860
Q24812326-997064C7-60C4-41D0-A8F8-5FAD03319A38Q33580516-5A28B8B9-9B7E-4749-A50C-7F7F8D5E7F49Q33580629-D53DDB81-3989-4758-B44C-D532EE550623Q33617543-8B309BF9-2655-4DDB-918B-B2B2E38DA85DQ35061170-6110A101-4FE2-47EA-908D-2C28AD2D3866Q35836467-A9B47CF9-7585-40F2-B5BD-33FB77D35FC3Q36059521-0A4D60BC-5E65-4F5A-9BD0-1F7802D50C47Q42230264-5ECF648A-5384-420B-90AF-CBAED2DD6100Q42611864-619C64D2-7769-4801-9344-D45F62D025F3Q44730636-2C367874-4FD1-4DDB-8937-D75D5565877CQ45114810-2214211E-9E6A-41CF-9746-81EDF45D1850Q46279970-B4FFCD56-A38A-4C71-B4B7-84F470E775ADQ47100094-B502CC00-1B95-4B95-8E78-D2C846D8C797Q58700161-8DAAAACE-F0F1-4B71-8858-7516B8DBEB9F
P2860
Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide receptor subtypes in mouse calvarial osteoblasts: presence of VIP-2 receptors and differentiation-induced expression of VIP-1 receptors.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Vasoactive intestinal peptide ...... expression of VIP-1 receptors.
@ast
Vasoactive intestinal peptide ...... expression of VIP-1 receptors.
@en
type
label
Vasoactive intestinal peptide ...... expression of VIP-1 receptors.
@ast
Vasoactive intestinal peptide ...... expression of VIP-1 receptors.
@en
prefLabel
Vasoactive intestinal peptide ...... expression of VIP-1 receptors.
@ast
Vasoactive intestinal peptide ...... expression of VIP-1 receptors.
@en
P2093
P356
P1433
P1476
Vasoactive intestinal peptide ...... expression of VIP-1 receptors.
@en
P2093
Lehenkari PP
Lundberg P
Lundgren I
Mukohyama H
P304
P356
10.1210/EN.142.1.339
P407
P50
P577
2001-01-01T00:00:00Z